WebMD reports:
...Within six months of a drug losing its patent, 80% of patients begin using its generic form. According to the IMS Institute’s most recent annual report, the average co-pays for generic drugs in 2010 were just over $6 as compared with nearly $24 for brand-name medications. That represents a huge potential savings for consumers....
So which drugs can you soon expect to see in generic form? Cholesterol lowering Lipitor; the anti-biotic Levaquin; Concerta, which treats symptoms of attention deficit hyperactivity disorder (ADHD), Protonix for the treatment of GERD (gastroesophageal reflux disease) and Zyprexa, which is used to treat symptoms of schizophrenia, all go off patent this year.
In 2012, the antidepressant Lexapro; Viagra for erectile dysfunction; Plavix, which prevents blood clots; and asthma medication Singulair are just a few of those losing their patents. For a full list you can see this report from market research firm, EvaluatePharma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment